Cross-talk between nuclear receptors and nuclear factor κB
- 30 October 2006
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 25 (51) , 6868-6886
- https://doi.org/10.1038/sj.onc.1209935
Abstract
A variety of studies have shown that some activated nuclear receptors (NRs), especially the glucorticoid receptor, the estrogen receptor and peroxisome proliferator-activated receptor, can inhibit the activity of the transcription factor nuclear factor κB (NF-κB), which plays a key role in the control of genes involved in inflammation, cell proliferation and apoptosis. This review describes the molecular mechanisms of cross-talk between NRs and NF-κB and the biological relevance of this cross-talk. The importance and mechanistic aspects of selective NR modulation are discussed. Also included are future research prospects, which will lead to a new era in the field of NR research with the aim of specifically inhibiting NF-κB-driven gene expression for anti-inflammatory, anti-tumor and immune-modulatory purposes.Keywords
This publication has 242 references indexed in Scilit:
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- Stress and the brain: from adaptation to diseaseNature Reviews Neuroscience, 2005
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- Partitioning and Plasticity of Repressive Histone Methylation States in Mammalian ChromatinMolecular Cell, 2003
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002